Recombinant GDF8 (Lintuzumab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant GDF8 (Lintuzumab Biosimilar) 抗体 (ABIN7543068)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Anti-CD33 [SGN-33 (Lintuzumab)], Human IgG1, kappa
-
特异性
- This antibody is specific for human CD33, which is restricted to cells of the myelomonocytic lineage. CD33 but does not appear in abundance on normal cells, but is over-expressed in AML and other myeloproliferative diseases.
-
产品特性
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
纯化方法
- Protein A affinity purified
-
免疫原
- This humanized antibody was prepared by combining the CDR regions of the murine anti-CD33 M195 with human framework and constant regions.
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
- In vitro, this antibody is capable of mediating ADCC against AML cells (Caron, 1998). Though shown to be safe in phase III trials, the use of this antibody in combination with induction chemotherapy did not result in a statistically significant improvement in response rate or survival in patients with refractory/relapsed AML (Feldman, 2005).
-
说明
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 0.02 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- GDF8 (Lintuzumab Biosimilar)
-
别名
- CD33 (Lintuzumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Sialic acid-binding Ig-like lectin 3, gp67, HuM195
-
UniProt
- P20138
抗原
-